Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 14/20 | 0.38 |
| ▸ | BCAT2 | O15382 | 12/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21653880 | 0.86 | BCAT1 (0.40) | BCAT1BCAT2MAPTHSD17B10TSHR | |
| SCHEMBL28425958 | 0.86 | BCAT1 (0.36) | BCAT1BCAT2MAPTSMN1; SMN2TSHR | |
| SCHEMBL21653846 | 0.84 | — | — | |
| SCHEMBL28425956 | 0.82 | BCAT2 (0.36) | BCAT1BCAT2 | |
| SCHEMBL26041116 | 0.76 | TSHR (0.35) | MAPTHSD17B10SMN1; SMN2TSHRALDH1A1 | |
| SCHEMBL21635539 | 0.74 | BCAT1 (0.42) | BCAT1BCAT2MAPTHSD17B10TSHR | |
| SCHEMBL29692736 | 0.73 | BCAT1 (0.41) | BCAT1BCAT2HSD17B10SMN1; SMN2TSHR | |
| SCHEMBL28359249 | 0.73 | BCAT1 (0.39) | BCAT1BCAT2MAPTHSD17B10TSHR | |
| SCHEMBL21635543 | 0.72 | BCAT1 (0.42) | BCAT1BCAT2MAPTHSD17B10TSHR | |
| SCHEMBL21653879 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3858829-B1 | METHOD FOR PREPARING ISOXAZOLINE-CONTAINING URACIL COMPOUND BY METHYLATION | SHENYANG SINOCHEM AGROCHEMICALS R & D CO LTD (CN) | 2024-05-01 | — | — | EP | disclosed |
| EP-3858829-A1 | METHOD FOR PREPARING ISOXAZOLINE-CONTAINING URACIL COMPOUND BY METHYLATION | Shenyang Sinochem Agrochemicals R & D Co., Ltd. (CN) | 2021-08-04 | — | — | EP | disclosed |
| US-10550111-B2 | Pyrimidine urea compound containing isoxazolines and use thereof | SHENYANG SINOCHEM AGROCHEMICALS R&D CO., LTD. (CN) | 2020-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550111-B2 | Pyrimidine urea compound containing isoxazolines and use thereof | DDX6, OAT, DHX36 | BCAT1 2789/4885BCAT2 2976/4885MAPT 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.